Advance the development of a medical countermeasure (MCM) evaluation platform that consists of vascular-immune and small intestine-immune organ-on-chip models, molecular assays, omics-based…
Active Definitive Contract Awarded Last action
- Contract number
- 75A50123C00042
- Awardee
-
The Charles Stark Draper Laboratory, Inc. UEI GTJHZE4M7YK1
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $45,863,892
Award facts
- Contract value 65% obligated
-
- $45,863,892.05 Current, with exercised options
- $70,063,892.05 Potential, with all options
- Completion date 62% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Cambridge, MA 02139, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $9,823,401 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,282,415 | |
| Other Administrative Action | $0 | |
| Additional Work (new agreement, FAR part 6 applies) | $8,096,757 | |
| Other Administrative Action | $0 | |
| Original award | $26,661,319 |
About this award
The Office of the Assistant Secretary for Preparedness and Response awarded a definitive contract to The Charles Stark Draper Laboratory, Inc. for development of a medical countermeasure evaluation platform on September 29, 2023, with a ceiling value of $70,063,892.05 and an ultimate completion date of September 28, 2028.
The contract, priced on a cost-plus-fixed-fee basis, funds the advancement of vascular-immune and small intestine-immune organ-on-chip models, molecular assays, omics-based technologies, and advanced analytical methods for biomarker discovery. Work is performed in Cambridge, MA.
The current modification exercises and funds Options 13 and 15, provides supplemental funding for Option 14, and updates program management oversight. Subcontractors include Sapient Bioanalytics LLC, Research and Diagnostic Systems Inc., Trustees of Boston University, and Battelle Memorial Institute's Pacific Northwest National Laboratory Division.
Description
Advance the development of a medical countermeasure (MCM) evaluation platform that consists of vascular-immune and small intestine-immune organ-on-chip models, molecular assays, omics-based technologies, advanced analytical methods for biomarker disc
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Sapient Bioanalytics, LLC | $43,600 | |
| L & Z Tool & Engineering Inc. | $155,000 | |
| Research And Diagnostic Systems, Inc. | $30,614 | |
| Research And Diagnostic Systems, Inc. | $35,945 | |
| L & Z Tool & Engineering Inc. | $135,000 | |
| Trustees Of Boston University | $2,016,279 | |
| Battelle Memorial Institute | $125,000 |
Quick answers
Who was awarded contract 75A50123C00042?
75A50123C00042 was awarded to The Charles Stark Draper Laboratory, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 29, 2023.
How much is contract 75A50123C00042 worth?
The government has obligated $45,863,892 on 75A50123C00042. Its potential value, with all options, is $70,063,892.
Was contract 75A50123C00042 competed?
The extent of competition for 75A50123C00042 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award